Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Myeloid cells as target of fingolimod action in multiple sclerosis.
Clinically isolated syndromes suggestive of multiple sclerosis: an optical coherence tomography study.
Genetic inactivation of mitochondria-targeted redox enzyme p66ShcA preserves neuronal viability and mitochondrial integrity in response to oxidative challenges.
A clinical and radiological profile of neuromyelitis optica and spectrum disorders in an Indian cohort.
Disease-Modifying Therapy of Pediatric Multiple Sclerosis.
[Pathogenesis of neuromyelitis optica].
The role of IL-6 in the expression of PD-1 and PDL-1 on CNS cells following infection with Theiler's murine encephalomyelitis virus.
Living with multiple sclerosis.
Progressive Injury in Chronic Multiple Sclerosis Lesions Is Gender-Specific: A DTI Study.
Elevated Lipid Profiles in Patients with Acute Transverse Myelitis.
Carbon Nanotube-Bilirubin Oxidase Bioconjugate as a New Biofuel Cell Label for Self-Powered Immunosensor.
Systematic Review: The effectiveness of interventions to reduce falls and improve balance in adults with multiple sclerosis.
Regulation of cerebrospinal fluid (CSF) flow in neurodegenerative, neurovascular and neuroinflammatory disease.
Chondroitin sulfate β-1,4-N-acetylgalactosaminyltransferase-1 (ChGN-1) polymorphism: Association with progression of multiple sclerosis.
The risks for falls and fractures in multiple sclerosis.
Differences in oligoclonal bands and visual evoked potentials in patients with radiologically and clinically isolated syndrome.
Treatment of cognitive impairment in patients with multiple sclerosis.
Polypharmacy in multiple sclerosis: Relationship with fatigue, perceived cognition, and objective cognitive performance.
2-Deoxy-d-glucose attenuates sevoflurane-induced neuroinflammation through nuclear factor-kappa B pathway in vitro.
Ranolazine Attenuates Mechanical Allodynia Associated with Demyelination Injury.
Sudden onset of sleep due to hypothalamic lesions in neuromyelitis optica spectrum disorder positive for anti-aquaporin-4 antibody.
Affinity Proteomic Profiling of Plasma, Cerebrospinal Fluid, and Brain Tissue within Multiple Sclerosis.
Trigeminal neuralgia: New classification and diagnostic grading for practice and research.
Dalfampridine prior authorization program: a cohort study.
Fine-Tuning of Regulatory T Cell Function: The Role of Calcium Signals and Naive Regulatory T Cells for Regulatory T Cell Deficiency in Multiple Sclerosis.
Pages
« first
‹ previous
…
342
343
344
345
346
347
348
349
350
…
next ›
last »